Concepedia

Charles D. Meyers

CD

15

Publications

897

Citations

14

H-Index

2003

Active since

Affiliations

Novartis (Switzerland)(Current)

University of California, Irvine

Novartis (United States)

University of Washington

Boston Biomedical Research Institute

Charles D. Meyers is an author at Novartis (Switzerland) specializing in medicine, pharmacology, and diabetes.

Top concepts

Publications per year

2003–2019

15

Publications

15

Niacin therapy in atherosclerosis

Charles D. Meyers, Vajinath S Kamanna, Moti L. Kashyap · Current Opinion in Lipidology · 2004 · 164 citations

Niacin therapy in atherosclerosis

Charles D. Meyers, Vajinath S Kamanna, Moti L. Kashyap · Current Opinion in Internal Medicine · 2005 · 139 citations

, , +7

Effect of the DGAT1 inhibitor pradigastat on triglyceride and apoB48 levels in patients with familial chylomicronemia syndrome

Charles D. Meyers, Karine Tremblay, Ahmed Amer et al. · Lipids in Health and Disease · 2015 · 106 citations · Full text

Bimagrumab improves body composition and insulin sensitivity in insulin‐resistant individuals

Tania Garito, Ronenn Roubenoff, Marcus Hompesch et al. · Diabetes Obesity and Metabolism · 2017 · 81 citations

The effects of licogliflozin, a dual SGLT1/2 inhibitor, on body weight in obese patients with or without diabetes

Yanling He, William G. Haynes, Charles D. Meyers et al. · Diabetes Obesity and Metabolism · 2019 · 80 citations

Rows per page

1–5 of 15